The research team also plan to investigate the drug in brain and colon cancer. The chemical's apparent gentleness means it could be used as a preventative drug in at-risk patients, she said. Professor Svanborg added: 'We believe the treatment points to new ways of reaching a balance between therapeutic efficacy and side effects.' Mats Persson, CEO of Hamlet Pharma Ltd, said: 'We need more evidence but hopefully this could be the gentle chemotherapy of the future.' Unlike conventional chemo, there was also no damage to healthy tissue. 'When it unfolds, it changes its function and forms tumoricidal complexes.'īladder cancer is the 10th most common form of the disease in the UK, with more than 10,300 people being diagnosed every year, according to Action Bladder Cancer UK.Īnd in the US, around 80,470 people are expected to develop bladder cancer in 2019, according to the National Cancer Institute.Įight of the nine patients passed tumour cells in just two hours, with the malignant masses also becoming smaller or less aggressive. 'Alpha1H aids in the production of lactose, the milk sugar that is essential for baby nutrition and to make the milk fluid,' she told The Telegraph. Britons 'at risk' from deadly Australian flu as the NHS scrambles to get hold of the right jabs in time for winter.Could this song ease YOUR pre-surgery anxiety? New study found calming music soothed patients as well as addictive drugs.Relaxing salt regulations in ready meals, bread and soup 'caused 9,900 cases of heart disease and 1,500 stomach cancer diagnoses'.Women with diabetes are up to 47% more likely than men to get heart failure 'because they take longer to diagnose and don't get the same level of care'.Professor Svanborg was amazed to discover the cancer cells were disappearing. It is common practice to do this on human cancer cells because they behave differently to other cells and can survive laboratory conditions, South China Morning Post reported. She was looking at how breast milk fights germs.

Professor Svanborg accidentally discovered alpha1H kills tumour cells while at Lund University, Sweden, in 1995. The research has been carried out by Motol University Hospital in Prague and was overseen by Professor Catharina Svanborg, who founded Hamlet Pharma Ltd. The milk sugar alpha1H, which is found only in breast milk, breaks tumours into tiny fragments that cancer patients can pass in their urine without damaging healthy tissue (stock)

The drug manufacturer Hamlet Pharma Ltd plans to test if the chemical shrinks bladder tumours and improves patient survival. Researchers from the Czech Republic hope this could be a 'gentler' form of chemo, with conventional treatments 'poisoning' cells and causing nasty side effects. When alpha1H binds to the fat oleic acid, they form a 'tumoricidal' complex that triggers cancerous cells into 'suicide'.

Further research suggests patients start to pass malignant tissue within two hours of treatment.

Tissue fragments in urine